Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
While this rapid evolution toward multi-agonist strategies and oral formulations promises enhanced efficacy, tolerability, and adherence, generating robust long-term safety and efficacy evidence remains imperative
D., Lambie, N
As a precaution, it is advisable to consult a healthcare provider before using this product
TB-500 provides critical enhancement of cellular migration and epithelial coverage that drives wound closure, with research demonstrating that topical or intraperitoneal TB-500 administration increases reepithelialization by 42% over controls at 4 days post-wounding and 61% at 7 days, with treated wounds showing enhanced contraction (at least 11% more than controls by day 7) and superior architectural organization
